Medisations - Bellingham, Washington 98229

Medisations is categorized under Business Services (Unclassified) in Bellingham, WA .

Business Name: Medisations
Address: 2111 Xenia Drive, Bellingham, Washington 98229
Phone Number: (360) 920-3633
Annual Revenue (USD): Unknown
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Services (Unclassified)
SIC Code: 7389
Share This Business:
Related Businesses: Eriksen Enterprises - Bellingham, WA 98229
Kim Villani - Bellingham, WA 98229
Halcyon Designs - Bellingham, WA 98229
Alabama Hill Adult Family Home - Bellingham, WA 98229
Guesthouse Inn Bellingham - Bellingham, WA 98229
Getusimmigrationhelp.com - Bellingham, WA 98229
D Knowles Family Corporation - Bellingham, WA 98229
Self employed - Bellingham, WA 98229
Chapbooks - Bellingham, WA 98229
Xografix - Bellingham, WA 98229
Estate Management Northwest - Bellingham, WA 98229
Ibach CO LLC - Bellingham, WA 98229
Zuzana Pikova & Associates - Bellingham, WA 98229
Electronic Processing System - Bellingham, WA 98229
Nice Systems - Bellingham, WA 98229
Sector 7g Systems LLC - Bellingham, WA 98229
Mrh Enterprises - Bellingham, WA 98229
Seguin Enterprises Inc - Bellingham, WA 98229
Bubbie's Bits N Bundles - Bellingham, WA 98229
Chromasafe Corp - Bellingham, WA 98229

The company Medisations provides B2B services in the form of Business Services (Unclassified) from its single location in Washington. 1 to 4 employees work for Medisations, and the business now earns Unknown per annum.

Medisations was launched in 0 and is classified under SIC code and category 7389 , and NAICS number and grouping . To contact Medisations, please call with the phone number (360) 920-3633 or visit its single location at 2111 Xenia Drive in Bellingham, Washington 98229.

The location of the single location can also be found using the coordinates 48.75868,-122.44461. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.